Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Strides Arcolab is currently trading at Rs 659.00, up by 13.70 points or 2.12% from its previous closing of Rs 645.30 on the BSE.
The scrip opened at Rs 650.00 and has touched a high and low of Rs 669.00 and Rs 645.50 respectively. So far 10365 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 681.00 on 20-Apr-2012 and a 52 week low of Rs 276.25 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs 677.75 and Rs 630.00 respectively. The current market cap of the company is Rs 3866.04 crore.
The promoters holding in the company stood at 28.35% while Institutions and Non-Institutions held 55.55% and 16.11% respectively.
Drug firm Strides Arcolab has reported a 15 fold jump in its consolidated net profit to Rs 642.07 crore for the first quarter ended March 31, 2012, primarily on the back of its entire stake sale in Australian arm Ascent Pharmahealth. The company had posted a net profit of Rs 40.71 crore in the same period last year.
The company’s net sales, on consolidated basis, stood at Rs 539.60 crore for the first quarter ended March 31, 2012, as against Rs 497.31 crore in the same period previous year.
On a standalone basis, the company posted a net loss of Rs 28.16 crore for the first quarter. It had posted a net profit of Rs 12.74 crore in the same period last year.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1517.90 |
| Dr. Reddys Lab | 6362.00 |
| Cipla | 1478.90 |
| Zydus Lifesciences | 1066.95 |
| Lupin | 1614.95 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
